NASDAQ : SHPH
Shuttle Pharmaceuticals Holdings, Inc. — Company profile
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 5.23 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 24.92M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Details
| Name | Shuttle Pharmaceuticals Holdings, Inc. |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 2 |
| Founded | 2012 |
| Ipo Date | 2022-08-31 |
| Ceo | Christopher Cooper |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 8.13 |
| Isin | US8256935003 |
| Cusip | 825693500 |
| Cik | 1757499 |
| Sic | 2834 |
Key executives
| Name | Title |
|---|---|
| Ryan Trasolini | Co-Chief Executive Officer |
| Christopher Robert Cooper BBA, M.B.A. | Interim Co-Chief Executive Officer and Director |
| Dr. Milton Brown CSC, M.D., Ph.D. | Co-Founder |
| Dr. Mira Jung Ph.D. | Co-Founder and Chief Scientific Officer for Biology |
| Yuying Liang B.A., CPA | Chief Financial Officer |
| Dr. Tyvin A. Rich M.D. | Chief Clinical Officer and Chief Medical Officer |
| Michael P. Vander Hoek | Vice President for Operations and Regulatory |
Contact
| Address | 401 Professional Drive, Suite 260, Gaithersburg, Maryland 20879, United States |
| Phone | 240 403 4212 |
| Website | https://www.shuttlepharma.com |